View Older Stories

Feb 26, 2026 04:49AM Mirum Pharmaceuticals (MIRM) PT Lowered to $132 at Citizens: Has Strong Momentum

Feb 5, 2026 08:52AM Mirum receives Health Canada approval for LIVMARLI tablet formulation

Feb 5, 2026 08:01AM Mirum Pharmaceuticals receives Health Canada approval for LIVMARLI treatment

Jan 26, 2026 06:49AM Mirum Pharmaceuticals (MIRM) PT Raised to $130 at H.C. Wainwright

Jan 15, 2026 04:16AM Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform: 'Top Pick' at Citizens

Jan 12, 2026 02:36PM Mirum Pharmaceuticals (MIRM) PT Raised to $95 at Baird

Jan 12, 2026 09:50AM TD Cowen on Mirum Pharmaceuticals (MIRM): 'Remain at Buy for base business and pipeline'

Jan 12, 2026 08:31AM Mirum Pharmaceuticals reports preliminary 2025 sales of $520 million

Jan 9, 2026 11:55AM Mirum launches phase 2 trial for Fragile X syndrome treatment

Dec 19, 2025 04:08PM Mirum sues generic drugmakers over Livmarli patent infringement

Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'

Dec 19, 2025 04:33AM Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expected

Dec 19, 2025 04:33AM Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expeected

Dec 11, 2025 06:38AM Mirum Pharmaceuticals (MIRM) PT Raised to $110 at Raymond James

Dec 10, 2025 02:38PM Mirum Pharmaceuticals (MIRM) PT Raised to $100 at Leerink Partners

Dec 9, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)

Dec 9, 2025 04:24AM Leerink Partners: 'MIRM’s Bluejay Deal Nice External Recognition of HDV Value; Positive for VIR'

Dec 8, 2025 03:52PM Mirum Pharmaceuticals (MIRM) PT Raised to $94 at Evercore ISI

Dec 8, 2025 03:01PM Morgan Stanley: 'we view the HDV program as promising and we view the transaction as a good fit for Mirum'

Dec 8, 2025 03:00PM Mirum Pharmaceuticals (MIRM) PT Raised to $88 at Baird

Nov 7, 2025 08:11AM Mirum presents liver disease drug data at AASLD conference

Nov 5, 2025 05:01AM Mirum Pharmaceuticals (MIRM) PT Raised to $95 at Citizens, Remains A Favorite

Nov 4, 2025 11:44PM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 20c ; Offers Guidance

Sep 24, 2025 03:20AM TD Cowen Starts Mirum Pharmaceuticals (MIRM) at Buy

Sep 17, 2025 04:16AM Citizens JMP Reiterates Market Outperform Rating on Mirum Pharmaceuticals (MIRM)

Aug 12, 2025 04:10PM Mirum Pharmaceuticals, Inc. (MIRM) Files Mixed Shelf

Aug 11, 2025 05:48AM Stifel Resumes Mirum Pharmaceuticals (MIRM) at Buy, PT $89, 'stands out in what remains a discerning biotech tape'

Aug 7, 2025 07:18AM Mirum Pharmaceuticals (MIRM) PT Raised to $80 at H.C. Wainwright

Aug 7, 2025 04:17AM Mirum Pharmaceuticals (MIRM) PT Raised to $81 at Citizens JMP

Aug 6, 2025 04:11PM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q2 EPS by 21c

May 19, 2025 08:52AM Mirum Pharmaceuticals, Inc. (MIRM) appoints Doug Sheehy as CLO

May 19, 2025 06:44AM H.C. Wainwright Starts Mirum Pharmaceuticals (MIRM) at Buy

May 9, 2025 04:40AM Mirum Pharmaceuticals (MIRM) PT Raised to $76 at Citizens JMP

May 8, 2025 05:20AM Mirum Pharamceuticals (MIRM) PT Raised to $76 at Evercore ISI

May 7, 2025 04:28PM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q1 EPS by 1c ; Offers Guidance

Apr 14, 2025 08:32AM Mirum Pharmaceuticals' (MIRM) LIVMARLI in tablet form receives FDA approval

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 27, 2025 08:33AM Mirum (MIRM) partner Takeda receives LIVMARLI approval in Japan

Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more

Feb 28, 2025 07:12AM Mirum Pharamceuticals (MIRM) PT Raised to $72 at H.C. Wainwright

Feb 26, 2025 04:40PM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q4 EPS by 155c

Feb 24, 2025 08:30AM Mirum Pharmaceuticals' (MIRM) CTEXLI Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis

Feb 24, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Mirum Pharamceuticals (MIRM)

Feb 21, 2025 11:56AM FDA approves Mirum Pharmaceuticals' (MIRM) genetic disorder drug

Jan 13, 2025 08:36AM Mirum Pharmaceuticals (MIRM) Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

Nov 13, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Nov 12, 2024 12:51PM Mirum Pharamceuticals (MIRM) PT Raised to $70 at Stifel

Nov 12, 2024 08:06AM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 15c ; Offers Guidance

Oct 11, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM), 'affirm MIRM shares as one of our 2024 Top Picks'

Oct 10, 2024 08:30AM Mirum Pharmaceuticals (MIRM) Announces Volixibat Granted FDA Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis

View Older Stories